home / stock / pstv / pstv quote
Last: | $ |
---|---|
Change Percent: | 2.29% |
Open: | $2.15 |
Close: | $2.23 |
High: | $2.29 |
Low: | $2.15 |
Volume: | 51,911 |
Last Trade Date Time: | 02/12/2020 04:43:17 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $2.15 | $2.23 | $2.29 | $2.15 | 51,911 | 02-12-2020 |
$ | $2.15 | $2.18 | $2.20 | $2.10 | 25,939 | 02-11-2020 |
$ | $2.17 | $2.165 | $2.1994 | $2.12 | 21,896 | 02-10-2020 |
$ | $2.24 | $2.17 | $2.24 | $2.16 | 29,417 | 02-07-2020 |
$ | $2.22 | $2.21 | $2.24 | $2.1356 | 40,541 | 02-06-2020 |
$ | $2.29 | $2.23 | $2.30 | $2.15 | 39,597 | 02-05-2020 |
$ | $2.21 | $2.26 | $2.30 | $2.10 | 60,207 | 02-04-2020 |
$ | $2.16 | $2.20 | $2.26 | $2.15 | 34,621 | 02-03-2020 |
$ | $2.15 | $2.18 | $2.24 | $2.1387 | 51,183 | 01-31-2020 |
$ | $2.25 | $2.21 | $2.29 | $2.10 | 79,714 | 01-30-2020 |
$ | $2.34 | $2.27 | $2.3497 | $2.23 | 55,807 | 01-29-2020 |
$ | $2.32 | $2.32 | $2.39 | $2.31 | 24,819 | 01-28-2020 |
$ | $2.30 | $2.33 | $2.40 | $2.19 | 41,151 | 01-27-2020 |
$ | $2.49 | $2.33 | $2.50 | $2.26 | 159,828 | 01-24-2020 |
$ | $2.50 | $2.495 | $2.5599 | $2.42 | 29,533 | 01-23-2020 |
$ | $2.59 | $2.50 | $2.6569 | $2.50 | 86,220 | 01-22-2020 |
$ | $2.66 | $2.5665 | $2.80 | $2.51 | 115,931 | 01-21-2020 |
$ | $2.75 | $2.71 | $2.86 | $2.68 | 83,828 | 01-20-2020 |
$ | $2.75 | $2.71 | $2.86 | $2.68 | 83,694 | 01-17-2020 |
$ | $2.70 | $2.72 | $2.94 | $2.6915 | 117,831 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NYSE Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
Plus Therapeutics Inc (NASDAQ:PSTV) has been selected for $3 million in funding recommendation by the Department of Defense (DoD) office of th...
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline Funding for pediatric brain cancer tre...